Viral gastroenteritis in adults

Recent Patents on Anti-Infective Drug Discovery

Volumn 6, Issue 1, 2011, Pages 54-63

  Eckardt, Alexander J ^a   Baumgart, Daniel C ^b  

^a DEUTSCHE KLINIK FÜR DIAGNOSTIK   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Gut; Infection; Intestinal; Vaccines; Viral gastroenteritis

Indexed keywords

ROTAVIRUS VACCINE; VIRUS VACCINE;

ACTIVE IMMUNIZATION; ADENOVIRUS; ARTICLE; ASTROVIRUS; CLINICAL FEATURE; DRUG EFFICACY; HUMAN; INFECTION PREVENTION; INTUSSUSCEPTION; NONHUMAN; NOROVIRUS; PRIORITY JOURNAL; ROTAVIRUS; STRUCTURE ANALYSIS; VIRAL GASTROENTERITIS; VIRUS LIKE AGENT; VIRUS MORPHOLOGY; VIRUS PATHOGENESIS; VIRUS REPLICATION; VIRUS TRANSMISSION;

ADENOVIRUSES, HUMAN; ADULT; ANTIVIRAL AGENTS; CHILD; GASTROENTERITIS; HUMANS; MAMASTROVIRUS; NOROVIRUS; ROTAVIRUS; VIRAL VACCINES;

EID: 79551654053     PISSN: 1574891X     EISSN: None     Source Type: Journal    
DOI: 10.2174/157489111794407877     Document Type: Article

References (151)

1. Dingle JH, Badger GF, Feller AE, Hodges RG, Jordan WS Jr, Rammelkamp CH Jr. A study of illness in a group of Cleveland families. I. Plan of study and certain general observations. Am J Hyg 1953; 58: 16-30.
2. Diez-Domingo J, Suriñach NL, Alcalde NM, Betegón L, Largeron N, Trichard M. Burden of paediatric rotavirus gastroenteritis (RVGE) and potential benefits of a universal rotavirus vaccination programme with a pentavalent vaccine in Spain. BMC Public Health 2010; 10: 469.
3. Chen KT, Fan SF, Tang RB, Huang YF, Lee PI, Chen PY, et al. Hospital-based study of the economic burden associated with rotavirus diarrhea in Taiwan. Vaccine 2007; 25: 4266-72.
4. Van der Wielen M, Giaquinto C, Gothefors L, Huelsse C, Huet F, Littmann M, et al. Impact of community-acquired paediatric rotavirus gastroenteritis on family life: Data from the REVEAL study. BMC Fam Pract 2010; 11: 22.
5. LeBaron CW, Furutan NP, Lew JF, Allen JR, Gouvea V, Moe C, et al. Viral agents of gastroenteritis. Public health importance and outbreak management. MMWR Recomm Rep 1990; 39: 1-24.
6. Wenman WM, Hinde D, Feltham S, Gurwith M. Rotavirus infection in adults. N Engl J Med 1979; 301: 303-6.
7. Blacklow NR, Greenberg HB. Viral gastroenteritis. N Engl J Med 1991; 325: 252-64.
8. de Wit MA, Koopmans MP, Kortbeek LM, Wannet WJ, Vinjé J, van Leusden F, et al. Sensor, a population-based cohort study on gastroenteritis in the Netherlands: Incidence and etiology. Am J Epidemiol 2001; 154: 666-74.
9. Leung WK, To KF, Chan PK, Chan HL, Wu AK, Lee N, et al. Enteric involvement of severe acute respiratory syndromeassociated coronavirus infection. Gastroenterology 2003; 125: 1011-7.
10. Wilhelmi I, Roman E, Sánchez-Fauquier. Viruses causing gastroenteritis. Clin Microbiol Infect 2003; 9: 247-62.
11. Kapoor A, Simmonds P, Slikas E, Li L, Bodhidatta L, Sethabutr O, et al. Human bocaviruses are highly diverse, dispersed, recombination prone, and prevalent in enteric infections. J Infect Dis 2010; 201: 1633-43.
12. Chow BD, Ou Z, Esper FP. Newly recognized bocaviruses (HBoV, HBoV2) in children and adults with gastrointestinal illness in the United States. J Clin Virol 2010; 47: 143-7.
13. Caul EOK, Paver K, Clarke SKR. Coronavirus particles in faeces from patients with gastroenteritis. Lancet 1975; 1: 1192.
14. Esper F, Ou Z, Huang YT. Human coronaviruses are uncommon in patients with gastrointestinal illness. J Clin Virol 2010; 48: 131-3.
15. Jamieson F, Wang EI, Bain C, Good J, Duckmanton L, Petric M. Human torovirus: A new nosocomial gastrointestinal pathogen. J Infect Dis 1998; 178: 1263-9.
16. Ambert-Balay K, Lorrot M, Bon F, Giraudon H, Kaplon J, Wolfer M, et al. Prevalence and genetic diversity of Aichi virus strains in stool samples from community and hospitalized patients. J Clin Microbiol 2008; 46: 1252-8.
17. Lin YH, Yeh CJ, Chen YJ, Chang MC, Su IH, Cheng HT. Recurrent cytomegalovirus colitis with megacolon in an immunocompetent elderly man. J Med Virol 2010; 82: 638-41.
18. Grohmann GS, Glass RI, Pereira HG, Monroe SS, Hightower AW, Weber R, et al. Enteric viruses and diarrhea in HIV-infected patients. N Engl J Med 1993; 329: 14-20.
19. Gallimore CI, Appleton H, Lewis D, Green J, Brown DW. Detection and characterisation of bisegmented double-stranded RNA viruses (picobirnaviruses) in human faecal specimens. J Med Virol 1995; 45: 135-40.
20. Hansman GS, Oka T, Katayama K, Takeda N. Human sapoviruses: Genetic diversity, recombination, and classification. Rev Med Virol 2007; 17: 133-41.
21. Glass RI, Parashar DU, Estes MK. Norovirus Gastroenteritis. N Engl J Med 2009; 361: 1776-85.
22. Nayak MK, Balasubramanian G, Sahoo GC, Bhattacharya R, Vinje J, Kobayashi N, et al. Detection of a novel intergenogroup recombinant norovirus from Kolkata, India. Virology 2008; 337: 177-23.
23. Bull RA, Tanaka MM, White PA. Norovirus recombination. J Gen Virol 2007; 88: 3347-59.
24. Tan M, Jiang X. Norovirus and its histo-blood group antigen receptors: An answer to a historical puzzle. Trends Microbiol 2005; 13: 285-93.
25. Ike AC, Hartelt K, Oehme RM, Brockmann SO. Detection and characterization of sapoviruses in outbreaks of gastroenteritis in southwest Germany. J Clin Virol 2008; 43: 37-41.
26. Hansman GS, Oka T, Sakon N, Takeda N. Antigenic diversity of human sapoviruses. Emerg Inf Dis 2007; 13: 1519-25.
27. Blacklow NR, Herrmann JE. Astrovirus gastroenteritis. Trans Am Clin Climatol Assoc 1995; 106: 58-66.
28. Guix S, Bosch A, Pintó RM. Human astrovirus diagnosis and typing: Current and future prospects. Lett Appl Microbiol 2005; 41: 103-5.
29. Finkbeiner SR, Holtz LR, Jiang Y, Rajendran P, Franz CJ, Zhao G, et al. Human stool contains a previously unrecognized diversity of novel astroviruses. Virol J 2009; 6: 161.
30. Nemerow GR, Pache L, Reddy V, Stewart PL. Insights into adenovirus host cell interactions from structural studies. Virology 2009; 384: 380-8.
31. Hammond GW, Hannan C, Yeh T, Fischer K, Mauthe G, Straus SE. DNA hybridization for diagnosis of enteric adenovirus infection from directly sptooted human fecal specimens. J Clin Microbiol 1987; 25: 1881-5.
32. Estes MK, Cohen J. Rotavirus gene structure and function. Microbiol Rev 1989; 53: 410-49.
33. Matsui SM, Mackow E, Greenberg HB. Molecular determinants of rotavirus neutralization and protection. Adv Virus Res 1989; 36: 181-214.
34. Chandran A, Fitzwater S, Zhen A, Santosham M. Prevention of rotavirus gastroenteritis in infants and children: Rotavirus vaccine safety, efficacy, and potential impact of vaccines. Biologics 2010; 4: 213-29.
35. Hung T, Chen G, Wang C, Yao HL, Fang ZY, Chao TX, et al. Waterborne outbreak of rotavirus diarrhea in adults in China caused by a novel rotavirus. Lancet 1984; 1: 1139-42.
36. Penaranda ME, Cubitt WD, Sinarachatanant P, Taylor DN, Likanonsakul S, Saif L, et al. Group C rotavirus infections in patients with diarrhea in Thailand, Nepal and England. J Infect Dis 1989; 160: 392-7.
37. Thielman NM, Guerrant RL. Acute infectious diarrhea. N Engl J Med 2004; 350: 38-47.
38. Guerrant RL, van Gilder T, Steiner TS, Thielman NM, Slutsker L, Tauxe RV, et al. Practice guidelines for the management of infectious diarrhea. Clin Infect Dis 2001; 32: 331
39. Cubitt WD, McSwiggan DA. Seroepidemiological survey of the prevalence of antibodies to a strain of human calicivirus. J Med Virol 1987; 21: 361-8.
40. Phillips G, Tam CC, Rodrigues LC, Lopman B. Prevalence and characteristics of asymptomatic norovirus infection in the community in England. Epidemiol Infect 2010; 138(10): 1454-8.
41. Kaplan JE, Feldman R, Campbell DS, Lookabauch C, Gary GW. The frequency of a Norwalk-like pattern of illness in outbreaks in acute gastroenteritis. Am J Public Health 1982; 72: 1329-32.
42. Fankhauser RL, Noel J, Monroe SS, Ando T, Glass RI. Molecular epidemiology of "Norwalk like viruses" in outbreaks of gastroenteritis in the United States. J Infect Dis 1998; 178: 1571-8.
43. Gary JJ, Wreghitt TG, Cubitt WD, Elliott PR. An outbreak of gastroenteritis in a home for the elderly associated with astrovirus type 1 and human calicivirus. J Med Virol 1987; 23: 377-81.
44. Musher DM, Musher BL. Contagious acute gastrointestinal infections. N Engl J Med 2004; 351: 2417-27.
45. Kaplan JE, Gary GW, Baron RC, Singh N, Schonberger LB, Feldman R, et al. Epidemiology of Norwalk gastroenteritis and the role of Norwalk virus in acute nonbacterial gastroenteritis. Ann Intern Med 1982; 96: 756-61.
46. Kirk MD, Fullerton KE, Hall GV, Gregory J, Stafford R, Veitch MG, et al. Surveillance for outbreaks of gastroenteritis in long-term care facilities, Australia, 2002-2008. Clin Infect Dis 2010; 51: 907-14.
47. Kirk MD, Roberts L, Horvath J. Understanding gastroenteritis in elderly residents of aged-care facilities. Med J Aust 2008; 189: 476-7.
48. Rosenthal NA, Lee LE, Vermeulen BA, Hedberg K, Keene WE, Widdowson MA, et al. Epidemiological and genetic characteristics of norovirus outbreaks in long-term care facilities, 2003-2006. Epidemiol Infect 2010: 1-9.
49. Reuter G, Pankovics P, Szucs G. Genetic drift of norovirus genotype GII-4 in seven consecutive epidemic seasons in Hungary. J Clin Virol 2008; 42: 135-40.
50. Phan TG, Kaneshi K, Ueda Y, Nakaya S, Nishimura S, Yamamoto A, et al. Genetic heterogeneity, evolution, and recombination in noroviruses. J Med Virol 2007; 79: 1388-400.
51. Donaldson EF, Lindesmith LC, Lobue AD, Baric RS. Viral shapeshifting: Norovirus evasion of the human immune system. Nat Rev Microbiol 2010; 8: 231-41.
52. Tu ET, Bull RA, Kim MJ, McIver CJ, Heron L, Rawlinson WD, et al. Norovirus excretion in an aged-care setting. J Clin Microbiol 2008; 46: 2119-21.
53. Atmar RL, Opekun AR, Gilger MA, Estes MK, Crawford SE, Neill FH, et al. Norwalk virus shedding after experimental human infection. Emerg Infect Dis 2008; 14: 1553-7.
54. Chiba S, Sakuma Y, Kogasaka R, Akihara M, Horino K, Nakao T, et al. An outbreak of gastroenteritis associated with calicivirus in an infant home. J Med Virol 1979; 4: 249-54.
55. Zintz C, Bok K, Parada E, Barnes-Eley M, Berke T, Staat MA, et al. Prevalence and genetic characterization of caliciviruses among children hospitalized for acute gastroenteritis in the United States. Infect Genet Evol 2005; 5: 281-90.
56. Yoshida T, Kasuo S, Azegami Y, Uchiyama Y, Satsumabayashi K, Shiraishi T, et al. Characterization of sapoviruses detected in gastroenteritis outbreaks and identification of asymptomatic adults with high viral load. J Clin Virol 2009; 45: 67-71.
57. Johansson PJ, Bergentoft K, Larsson PA, Magnusson G, Widell A, Thorhagen M, et al. A nosocomial sapovirus-associated outbreak of gastroenteritis in adults. Scand J Infect Dis 2005; 37: 200-4.
58. Mikula C, Springer B, Reichart S, Bierbacher K, Lichtenschopf A, Hoehne M. Sapovirus in adults in rehabilitation center, upper Austria. Emerg Infect Dis 2010; 16: 1186-7.
59. Svraka S, Vennema H, van der Veer B, Hedlund KO, Thorhagen M, Siebenga J, et al. Epidemiology and genotype analysis of emerging sapovirus-associated infections across Europe. J Clin Microbiol 2010; 48: 2191-8.
60. Pang XL, Lee BE, Tyrrell GJ, Preiksaitis JK. Epidemiology and genotype analysis of sapovirus associated with gastroenteritis outbreaks in Alberta, Canada: 2004-2007. J Infect Dis 2009; 199: 547-51.
61. Hansman GS, Sano D, Ueki Y, Imai T, Oka T, Katayama K, et al. Sapovirus in water, Japan. Emerg Infect Dis 2007; 13: 133-5.
62. Yamashita Y, Ootsuka Y, Kondo R, Oseto M, Doi M, Miyamoto T, et al. Molecular characterization of Sapovirus detected in a gastroenteritis outbreak at a wedding hall. J Med Virol 2010; 82: 720-6.
63. Iizuka S, Oka T, Tabara K, Omura T, Katayama K, Takeda N, et al. Detection of sapoviruses and noroviruses in an outbreak of gastroenteritis linked genetically to shellfish. J Med Virol 2010; 82: 1247-54.
64. Pager CT, Steele AD. Astrovirus-associated diarrhea in South African adults. Clin Infect Dis 2002; 35: 1452-3.
65. Glass RI, Noel J, Mitchell D, Herrmann JE, Blacklow NR, Pickering LK, et al. The changing epidemiology of astrovirusassociated gastroenteritis: A review. Arch Virol Suppl 1996; 12: 287-300.
66. Verma H, Chitambar SD, Gopalkrishna V. Astrovirus associated acute gastroenteritis in western India: Predominance of dual serotype strains. Infect Genet Evol 2010; 10: 575-9.
67. Marshall JA, Bruggink LD, Sturge K, Subasinghe N, Tan A, Hogg GG. Molecular features of astrovirus associated with a gastroenteritis outbreak in an aged-care centre. Eur J Clin Microbiol Infect Dis 2007; 26: 67-71.
68. Huhulescu S, Kiss R, Brettlecker M, Cerny RJ, Hess C, Wewalka G, et al. Etiology of acute gastroenteritis in three sentinel general practices, Austria 2007. Infection 2009; 37: 103-8.
69. Kittigul L, Pombubpa K, Taweekate Y, Yeephoo T, Khamrin P, Ushijima H. Molecular characterization of rotaviruses, noroviruses, sapovirus, and adenoviruses in patients with acute gastroenteritis in Thailand. J Med Virol 2009; 81: 345-53.
70. Kotloff KL, Losonsky GA, Morris JG Jr, Wasserman SS, Singh-Naz N, Levine MM. Enteric adenovirus infection and childhood diarrhea: An epidemiologic study in three clinical settings. Pediatrics 1989; 84: 219-25.
71. Filho EP, da Costa Faria NR, Fialho M, de Assis RS, Almeida MM, Rocha M, et al. Adenoviruses associated with acute gastroenteritis in hospitalized and community children up to 5 years old in Rio de Janeiro and Salvador, Brazil. J Med Microbiol 2007; 56: 313-9.
72. Cunliffe NA, Booth JA, Elliot C, Lowe SJ, Sopwith W, Kitchin N, et al. Healthcare-associated viral gastroenteritis among children in a large pediatric hospital, United Kingdom. Emerg Infect Dis 2010; 16: 55-62.
73. Rodriguez WJ, Kim HW, Brandt CD, Schwartz RH, Gardner MK, Jeffries B, et al. Fecal adenoviruses from a longitudinal study of families in metropolitan Washington, DC. laboratory, clinical, and epidemiologic observations. J Pediatr 1985; 107: 514-20.
74. Wenman WM, Hinde D, Feltham S, Gurwith M. Rotavirus infection in adults: Results of a prospective family study. N Engl J Med 1979; 301: 303-6.
75. Echeverria P, Blacklow NR, Cukor GG, Vivulbandhitkit S, Changchawalit S, Boonthai P. Rotavirus as a cause of severe gastroenteritis in adults. J Clin Microbiol 1983; 18: 663-7.
76. Liu LJ, Liu W, Liu YX, Xiao HJ, Jia N, Liu G, et al. Identification of norovirus as the top enteric viruses detected in adult cases with acute gastroenteritis. Am J Trop Med Hyg 2010; 82(4): 717-22.
77. Lopman BA, Reacher MH, van Duijnhoven Y, Hanon F-X, Brown D, Koopmans M. Viral gastroenteritis outbreaks in Europe, 1995-2000. Emerg Infect Dis 2003; 9: 90-6.
78. Hopkins RS, Gaspard GB, Williams FPJ, Karlin RJ, Cukor G, Blacklow NR. A community waterborne gastroenteritis outbreak: Evidence for Rotavirus as the agent. Am J Public Health 1984; 74: 263-5.
79. Dennehy PH. Transmission of rotavirus and other enteric pathogens in the home. Pediatr Infect Dis 2000; 19: S103-5.
80. Svraka S, Duizer E, Vennema H, de Bruin E, van der Meer B, Dorresteijn B, et al. Etiological role of viruses in Outbreaks of acute gastroenteritis in the Netherlands from 1994 through 2005. J Clin Microbiol 2007; 45: 1389-94.
81. Shepherd RW, Gall DG, Butler dG, Hamilton JR. Determinants of diarrhea in viral enteritis. The role of ion transport and epithelial changes in the ileum in transmissible gastroenteritis in piglets. Gastroenterology 1976; 76: 20.
82. Schreiber DS, Blacklow NR, Trier JS. The mucosal lesion of the proximal small intestine in acute infectious nonbacterial gastroenterits. N Engl J Med 1973; 288: 1318.
83. Agus SG, Dolin R, Wyatt RG, Tousimis AJ, Northrup RS. Acute infectious nonbacterial gastroenteritis: Intestinal histopathology. Histologic and enzymatic alterations during illness produced by the Norwalk agent in man. Ann Intern Med 1973; 79: 18-25.
84. Heyman M, Corthier G, Petit A, Meslin JC, Moreau C, Desjeux JF. Intestinal absorption of macromolecules during viral enteritis: An experimental study on rotavirus-infected conventional and germfree mice. Pediatr Res 1987; 22: 72-8.
85. Keljo DJ, Butler DG, Hamilton JR. Altered jejunal permeability to macromolecules during viral enteritis in the piglet. Gastroenterology 1985; 88: 998-1004.
86. Lorrot M, Vasseur M. How do the rotavirus NSP4 and bacterial enterotoxins lead differently to diarrhea? Virol J 2007; 4: 31.
87. Wadl M, Scherer K, Nielsen S, Diedrich S, Ellerbroek L, Frank C, et al. Food-borne norovirus-outbreak at a military base, Germany,2009. BMC Infect Dis 2010; 10: 30.
88. Grotto I, Huerta M, Balicer RD, Halperin T, Cohen D, Orr N, et al. An outbreak of norovirus gastroenteritis on an Israeli military base. Infection 2004; 32(6): 339-43.
89. Mattner F, Sohr D, Heim A, Gastmeier P, Vennema H, Koopmans M. Risk groups fo clinical complications of norovirus infections: An outbreak investigation. Clin Microbiol Infect 2006; 12: 69-74.
90. Centers for Disease Control and Prevention (CDC). Norovirus activity--United States, 2006-2007. MMWR Morb Mortal Wkly Rep 2007; 56(33): 842-6.
91. Dey SK, Phan TG, Nguyen TA, Nishio O, Salim AF, Yagyu F, et al. Prevalence of sapovirus infection among infants and children with acute gastroenteritis in Dhaka City, Bangladesh during 2004-2005. J Med Virol 2007; 79: 633-8.
92. Usuku S, Kumazaki M, Kitamura K, Tochikubo O, Noguchi Y. An outbreak of food-borne gastroenteritis due to sapovirus among junior high school students. Jpn J Infect Dis 2008; 61: 438-41.
93. Kurtz JB, Lee TW, Craig JW, Reed SE. Astrovirus infection in volunteers. J Med Virol 1979; 3: 221-30.
94. Marshall JA, Bruggink LD, Sturge K, Subasinghe N, Tan A, Hogg GG. Molecular features of astrovirus associated with a gastroenteritis outbreak in an aged-care centre. Eur J Clin Microbiol Infect Dis 2007; 261: 67-71.
95. Uhnoo I, Olding-Stenkvist E, Kreuger A. Clinical features of acute gastroenteritis associated with rotavirus, enteric adenoviruses, and bacteria. Arch Dis Child 1986; 61: 732-8.
96. Chiba S, Nakata S, Nakamura I, Taniguchi K, Urasawa S, Fujinaga K, et al. Outbreak of infantile gastroenteritis due to type 40 adenovirus. Lancet 1983; 2: 954-7.
97. Richmond SJ, Caul EO, Dunn SM, Ashley CR, Clarke SK, Seymour NR. An outbreak of gastroenteritis in young children caused by adenoviruses. Lancet 1979; 1178-81.
98. Kapikian AZ, Wyatt RG, Levine MM, Yolken RH, VanKirk DH, Dolin R, et al. Oral administration of human rotavirus to volunteers: Induction of illness and correlates of resistance. J Infect Dis 1983; 147: 95-106.
99. Ward RL, Bernstein DI, Young EC, Sherwood JR, Knowlton DR, Schiff GM. Human rotavirus studies in volunteers: Determination of infectious dose and serological response to infection. J Infect Dis 1986; 154: 871-80.
100. Clark B, McKendrick M. A review of viral gastroenteritis. Curr Opin Infect Dis 2004; 17: 461-69.
101. Noppornpanth S, Poovorawan Y. Comparison between RT-PCR and rapid agglutination test for diagnosis of human rotavirus infection. Southeast Asian J Trop Med Public Health 1999; 30: 707-9.
102. Atmar RL, Estes MK. Diagnosis of noncultivatable gastroenteritis viruses, the human caliciviruses. Clin Microbiol Rev 2001; 14: 15-37.
103. Gray JJ, Kohli E, Ruggeri FM, Vennema H, Sánchez-Fauquier A, Schreier E, et al. European multicenter evaluation of commercial enzyme immunoassays for detecting norovirus in fecal samples. Clin Vaccine Immunol 2007; 14: 1349-55.
104. Trujillo AA, McCaustland KA, Zheng DP, Hadley LA, Vaughn G, Adams SM, et al. Use of TaqMan real-time reverse transcription- PCR for rapid detection, quantification, and typing of norovirus. J Clin Microbiol 2006; 44: 1405-12.
105. van Maarseveen NM, Wessels E, de Brouwer CS, Vossen AC, Claas EC. Diagnosis of viral gastroenteritis by simultaneous detection of Adenovirus group F, Astrovirus, Rotavirus group A, Norovirus genogroups I and II, and Sapovirus in two internally controlled multiplex real-time PCR assays. J Clin Virol 2010; 49: 205-10.
106. Nordgren J, Bucardo F, Svensson L, Lindgren PE. J Novel lightupon- extension real-time PCR assay for simultaneous detection, quantification, and genogrouping of group A rotavirus. Clin Microbiol 2010; 48: 1859-65.
107. Paul, III J.H., Casper, E.T., Patterson, S.S. Materials and methods for detection of enterovirus and norovirus. US20070160983 (2007).
108. Masuda, N., Yasukawa, K., Horie, R. Norovirus detection reagent. US20090181365 (2009).
109. Hahn S, Kim S, Garner P. Reduced osmolarity oral rehydration solution for treating dehydration due to dehydration in children: Systematic review. BMJ 2001; 323: 81-5.
110. Rossignol JF. Thiazolides: A new class of antiviral drugs. Expert Opin Durg Metab Toxicol 2009; 667-74.
111. Pulling M, Surawicz CM. Loperamide use for acute infectious diarrhea in children: Safe and sound? Gastroenterology 2008; 134: 1260-2.
112. Hanauer SB. The role of loperamide in gastrointestinal disorders. Rev Gastroenterol Disord 2008; 8: 15-20.
113. Cézard JP, Duhamel JF, Meyer M, Pharaon I, Bellaiche M, Maurage C, et al. Efficacy and tolerability of racecadotril in acute diarrhea in children. Gastroenterology 2001; 120: 799-805.
114. Salazar-Lindo E, Santisteban-Ponce J, Chea-Woo E, Gutierrez M. Racecadotril in the treatment of acute watery diarrhea in children. N Engl J Med 2000; 343: 463-7.
115. Isolauri E, Vähäsarja V, Vesikari T. Effect of cholestyramine on acute diarrhoea in children receiving rapid oral rehydration and full feedings. Ann Clin Res 1986; 18: 99-102.
116. Guarino A, Lo Vecchio A, Canani RB. Probiotics as prevention and treatment for diarrhea. Curr Opin Gastroenterol 2009; 25: 18-23.
117. Arigoni, F., Bruessow, H., Cavadini, C., Page, N. Prevention and treatment of rotavirus diarrhea. WO2010069737 (2010).
118. King CK, Glass R, Bresee JS, Duggan C. Managing acute gastroenteritis among children. MMWR 2003; 52: 1-16.
119. Rodrigo C, Salman N, Tatochenko V, Mészner Z, Giaquinto C. Recommendations for rotavirus vaccination: A worldwide perspective. Vaccine 2010; 28: 5100-8.
120. Ozawa K, Oka T, Takeda N, Hansman GS. Norovirus infections in symptomatic and asymptomatic food handlers in Japan. J Clin Microbiol 2007; 45: 3996-4005.
121. Sandora TJ, Shih MC, Goldmann DA. Reducing abseentism from gastrointestinal and respiratory illness in elementary school students: A randomized controlled trial of an infection control intervention. Pediatrics 2008; 121: e1555-62.
122. Belliot G, Lavaux A, Souihel D, Agnello D, Pothier P. Use of murine norovirus as a surrogate to evaluate resistance of human norovirus to disinfectants. Appl Environ Microbiol 2008; 74: 3315-8.
123. Koo HL, Ajami N, Atmar RL, DuPont HL. Noroviruses: The leading cause of gastroenteritis worldwide. Discov Med 2010; 10: 61-70.
124. Chang KO, George DW. Interferons and ribavirin effectively inhibit Norwalk virus replication in replicon-bearing cells. J Virol 2007; 81: 2111-8.
125. Pitzer VE, Viboud C, Simonsen L, Steiner C, Panozzo CA, Alonso WJ, et al. Demographic variability, vaccination, and the spatiotemporal dynamics of rotavirus epidemics. Science 2009; 325: 290-4.
126. Santosham M. Rotavirus vaccine - a powerful tool to combat deaths from diarrhea. N Engl J Med 2010; 326: 358-60.
127. Meeting of the immunization strategic advisory group of Experts. April 2009 - conclusions and recommendations. Wkly Epidemiol Rec 2009; 84: 220-36.
128. Ruiz-Palacios GM, Pérez-Schael I, Veláquez R, Abate H, Breuer T, Clemens SC, et al. Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. N Engl J Med 2006; 354: 11-22.
129. Vesikari T, Matson DO, Dennehy P, Santosham M, Rodriguez Z, Dallas MJ, et al. Safety and efficacy of a pentavalent humanbovine (WC3) reassortant rotavirus vaccine. N Engl J Med 2006; 354: 23-33.
130. Madhi SA, Cunliffe NA, Steele D, Witte D, Kirsten M, Louw C, et al. Effect of human rotavirus vaccine on severe diarrhea in African infants. N Engl J Med 2010; 362: 289-98.
131. Murphy TV, Gargiullo PM, Massoudi MS, Nelson DB, Jumaan AO, Okoro CA, et al. Intussusception among infants given an oral rotavirus vaccine. N Engl J Med 2001; 344: 564-72.
132. Schaetti C. Vaccines for enteric diseases: Update on recent developments. Expert Rev Vaccines 2009; 8: 1653-5.
133. Victoria JG, Wang C, Jones MS, Jaing C, McLoughlin K, Gardner S, et al. Viral nucleic acids in live-attenuated vaccines: detection of minority variants and an adventitious virus. J Virol 2010; 84(12): 6033-40.
134. Kuehn BM. FDA: Benefits of rotavirus vaccination outweigh potential contamination risk. JAMA 2010; 304: 30-1.
135. Chandran A, Fitzwater S, Zhen A. Prevention of rotavirus gastroenteritis in infants and children: Rotavirus vaccine safety, efficacy, and potential impact of vaccines. Santosham M. Biologics 2010; 4: 213-29.
136. Colau, B.D.A., Arsene B, De Vos, B.A.V. Immunization with an attenuated human rotavirus. US7579008B2 (2009).
137. Vande, V.V. Live attenuated rotavirus vaccine for oral administration. US20080166372 (2008).
138. Dormitzer, P.R., Harrison, S.C., Greenberg, H.B., Yoder, J. Rotavirus antigens. US20070276130 (2007).
139. Kapikian, A.Z., Chanock, R., Veskari, T. Compositions and method for preventing reactogenicity associated with administration of immunogenic live rotavirus compositions. US7431931B2 (2008).
140. Estes MK, Ball JM, Guerrero RA, Opekun AR, Güger MA, Pacheco SS, et al. Norwalk virus vaccines: Challenges and progress. J Infect Dis 2000; 181: S367-73.
141. Prasad BV, Rothnagel R, Jiang X, Estes MK. Three-dimensional structure of baculovirus-expressed Norwalk virus capsids. J Virol 1994; 68: 5117-25.
142. Mason HS, Ball JM, Shi JJ, Jiang X, Estes MK, Arntzen CJ. Expression of Norwalk virus capsid protein in transgenic tobacco and potato and its oral immunogenicity in mice. Proc Natl Acad Sci USA 1996; 93: 5335-40.
143. Ball JM, Graham DY, Opekun AR, Gilger MA, Guerrero RA, Estes MK. Recombinant Norwalk virus-like particles given orally to volunteers: Phase I study. Gastroenterology 1999; 117: 40-8.
144. Guerrero RA, Ball JM, Krater SS, Pacheco SE, Clements JD, Estes MK. Recombinant Norwalk virus-like particles administered intranasally to mice induce systemic and mucosal (fecal and vaginal) immune responses. J Virol 2001; 75: 9713-22.
145. El-Kamary SS, Pasetti MF, Mendelman PM, Frey SE, Bernstein DI, Treanor JJ, et al. Adjuvanted intranasal Norwalk virus-like particle vaccine elicits antibodies and antibody-secreting cells that express homing receptors for mucosal and peripheral lymphoid tissues. J Infect Dis 2010; 202: 1649-58.
146. Vinjé J. A norovirus vaccine on the horizon? J Infect Dis 2010; 202(11): 1623-5.
147. Santi L, Batchelor L, Huang Z, Hjelm B, Kilbourne J, Arntzen CJ, et al. An efficient plant viral expression system generating orally immunogenic Norwalk virus-like particles. Vaccine 2008; 26: 1846-54.
148. Richardson, C., Vedvick, T.S., Foubert, T.R. Method of conferring a protective immune response to norovirus. US20100266636 (2010).
149. Richardson, C., Vedvick, T.S., Foubert, T.R. Norovirus vaccine formulations. US20080299152 (2008).
150. Jiang, X., Tan, M. Novel norovirus particle for use as an antiviral or vaccine. US20090280139 (2009).
151. Coit, D., Houghton, M., McCoin, C., Medina-Selby, A., Vaijdy, M. Norovirus and sapovirus antigens. US20100291129 (2010).